Free Trial

36,711 Shares in KKR & Co. Inc. (NYSE:KKR) Purchased by Dorsey Wright & Associates

KKR & Co. Inc. logo with Finance background
Remove Ads

Dorsey Wright & Associates purchased a new position in shares of KKR & Co. Inc. (NYSE:KKR - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 36,711 shares of the asset manager's stock, valued at approximately $5,430,000. KKR & Co. Inc. makes up about 1.3% of Dorsey Wright & Associates' investment portfolio, making the stock its 24th biggest holding.

Other institutional investors and hedge funds also recently made changes to their positions in the company. AdvisorNet Financial Inc raised its stake in KKR & Co. Inc. by 417.8% during the 4th quarter. AdvisorNet Financial Inc now owns 2,180 shares of the asset manager's stock worth $322,000 after buying an additional 1,759 shares during the period. Whalen Wealth Management Inc. acquired a new stake in shares of KKR & Co. Inc. during the fourth quarter worth about $667,000. Caldwell Investment Management Ltd. raised its position in shares of KKR & Co. Inc. by 2.9% during the fourth quarter. Caldwell Investment Management Ltd. now owns 212,400 shares of the asset manager's stock worth $31,477,000 after purchasing an additional 5,900 shares during the period. Jupiter Asset Management Ltd. lifted its holdings in shares of KKR & Co. Inc. by 50.9% during the 4th quarter. Jupiter Asset Management Ltd. now owns 114,184 shares of the asset manager's stock valued at $16,889,000 after purchasing an additional 38,524 shares in the last quarter. Finally, Sanctuary Advisors LLC grew its position in shares of KKR & Co. Inc. by 31.1% in the 3rd quarter. Sanctuary Advisors LLC now owns 92,741 shares of the asset manager's stock valued at $12,110,000 after purchasing an additional 22,007 shares during the period. Institutional investors and hedge funds own 76.26% of the company's stock.

Remove Ads

KKR & Co. Inc. Stock Up 2.7 %

KKR traded up $3.15 during trading on Wednesday, reaching $120.99. 4,048,098 shares of the stock were exchanged, compared to its average volume of 4,623,689. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.07 and a current ratio of 0.07. The stock's 50 day moving average price is $134.37 and its two-hundred day moving average price is $141.62. KKR & Co. Inc. has a twelve month low of $91.92 and a twelve month high of $170.40. The stock has a market cap of $107.47 billion, a P/E ratio of 36.33, a price-to-earnings-growth ratio of 1.00 and a beta of 1.72.

KKR & Co. Inc. Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were paid a dividend of $0.175 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.70 annualized dividend and a dividend yield of 0.58%. KKR & Co. Inc.'s dividend payout ratio is presently 21.02%.

Insider Activity

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of KKR & Co. Inc. stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the completion of the transaction, the insider now directly owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. The trade was a 23.75 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 39.34% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Keefe, Bruyette & Woods cut their price target on shares of KKR & Co. Inc. from $170.00 to $168.00 and set an "outperform" rating on the stock in a research note on Monday, January 13th. Oppenheimer increased their target price on KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an "outperform" rating in a report on Thursday, December 12th. Barclays cut their price target on KKR & Co. Inc. from $185.00 to $181.00 and set an "overweight" rating on the stock in a report on Wednesday, February 5th. Wells Fargo & Company raised KKR & Co. Inc. from an "equal weight" rating to an "overweight" rating and reduced their price objective for the stock from $150.00 to $141.00 in a research report on Thursday, March 20th. Finally, HSBC lowered KKR & Co. Inc. from a "buy" rating to a "hold" rating and lifted their target price for the company from $153.00 to $173.00 in a research report on Thursday, January 30th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $160.79.

Check Out Our Latest Stock Report on KKR & Co. Inc.

KKR & Co. Inc. Company Profile

(Free Report)

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.

Read More

Institutional Ownership by Quarter for KKR & Co. Inc. (NYSE:KKR)

Should You Invest $1,000 in KKR & Co. Inc. Right Now?

Before you consider KKR & Co. Inc., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KKR & Co. Inc. wasn't on the list.

While KKR & Co. Inc. currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is the dip in Micron's stock price a golden buying opportunity or another case of dead money? MarketBeat's Thomas Hughes weighs in, comparing Micron to AMD.

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads